A randomized, double-blind, placebo-controlled, crossover trial to assess the effects of zafirlukast (ACCOLATE) 20 mg twice daily when administered with food on exercise-induced bronchoconstriction induced in subjects with asthma.
Study identifier:9188US/0025
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A randomized, double-blind, placebo-controlled, crossover trial to assess the effects of zafirlukast (ACCOLATE) 20 mg twice daily when administered with food on exercise-induced bronchoconstriction induced in subjects with asthma.
Medical condition
asthma
Phase
Phase 4
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Feb 1999
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
